Your browser doesn't support javascript.
loading
Outcomes of transvenous lead extraction using the TightRail™ mechanical rotating dilator sheath and excimer laser sheath.
Misra, Satish; Swayampakala, Kamala; Coons, Patricia; Cerbie, Claire; Guifarro, Angello; Lesiczka, Magdalena; Holshouser, John W; Madjarov, Jeko; Love, Charles; Mehta, Rohit.
Afiliação
  • Misra S; Sanger Heart and Vascular Institute, Atrium Health, Charlotte, North Carolina, USA.
  • Swayampakala K; Sanger Heart and Vascular Institute, Atrium Health, Charlotte, North Carolina, USA.
  • Coons P; Sanger Heart and Vascular Institute, Atrium Health, Charlotte, North Carolina, USA.
  • Cerbie C; Sanger Heart and Vascular Institute, Atrium Health, Charlotte, North Carolina, USA.
  • Guifarro A; Sanger Heart and Vascular Institute, Atrium Health, Charlotte, North Carolina, USA.
  • Lesiczka M; Sanger Heart and Vascular Institute, Atrium Health, Charlotte, North Carolina, USA.
  • Holshouser JW; Sanger Heart and Vascular Institute, Atrium Health, Charlotte, North Carolina, USA.
  • Madjarov J; Sanger Heart and Vascular Institute, Atrium Health, Charlotte, North Carolina, USA.
  • Love C; Division of Cardiology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Mehta R; Sanger Heart and Vascular Institute, Atrium Health, Charlotte, North Carolina, USA.
J Cardiovasc Electrophysiol ; 32(7): 1969-1978, 2021 07.
Article em En | MEDLINE | ID: mdl-34028112
ABSTRACT

BACKGROUND:

Transvenous lead extraction (TLE) is an important part of comprehensive lead management. The selection of tools available has expanded in recent years but data on their efficacy is limited.

OBJECTIVE:

To evaluate outcomes using the TightRail™ mechanical rotating mechanical dilator sheath in comparison to excimer laser sheaths and describe factors predictive of successful extraction.

METHODS:

Patients undergoing TLE at a single tertiary center (2013-2019) were included in a prospective registry. Leads targeted for extraction with either an SLS II/Glidelight™ or TightRail™ sheath were included. Outcomes were analyzed on a per-lead basis. Generalized estimating equation (GEE) models were used to assess differences in lead extraction success by extraction tool used while adjusting for nonindependence of multiple leads extracted from the same patient. Covariates included patient comorbidities, lead characteristics, and sheath size.

RESULTS:

A total of 575 leads extracted from 372 patients were included. Overall success rate was 97%. TightRail™ was the first tool used in 180 (31.3%) leads with success rate of 61.7%; laser sheaths were the first tool in 395 leads (68.7%) with success rate of 67.8%. Predictors of successful extraction included lead age, lead type, and sheath sizing. Extraction success did not differ based on whether a laser or TightRail™ sheath was used (adjusted odds ratio = 0.94; 95% confidence interval = 0.59-1.50).

CONCLUSION:

The TightRail™ sheath is an effective tool for TLE. Lead age, lead type, and sheath sizing were predictive of successful extraction but sheath type was not. These findings are hypothesis generating and warrant further investigation in a prospective, randomized study.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Marca-Passo Artificial / Desfibriladores Implantáveis Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Marca-Passo Artificial / Desfibriladores Implantáveis Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article